Learn more

BTG INT LTD

Overview
  • Total Patents
    1,385
  • GoodIP Patent Rank
    34,642
  • Filing trend
    ⇧ 1400.0%
About

BTG INT LTD has a total of 1,385 patent applications. It increased the IP activity by 1400.0%. Its first patent ever was published in 1985. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NOVARTIS AG *, ORION YHTYMAE OYJ and ALLERGAN INC.

Patent filings per year

Chart showing BTG INT LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Harman Anthony David 113
#2 Wright David Dakin Iorwerth 83
#3 Robinson Nikki 47
#4 Hodges Garry 45
#5 Harbige Laurence S 41
#6 Moggridge Geoffrey D 40
#7 Leach Michael J 40
#8 Kadar Adil 39
#9 Osman Tariq 39
#10 Ward Ian Macmillan 35

Latest patents

Publication Filing date Title
US2020197402A1 Platinum-resistant cancer treatment
CA3062552A1 Platinum-resistant cancer treatment
US2016279233A1 Epitopes related to coeliac disease
JP2012246306A Injectable foam preparation, and new pharmaceutical application
AU2011247868A1 Epitopes related to coeliac disease
AU2010295311A1 Reconstitutable reverse thermal gelling polymers
GB0919950D0 Clamp and applicator
GB0917775D0 Novel pharmaceutical compounds
US2009253781A1 Therapeutic compositions
CA2717954A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia
GB0901836D0 EP4 receptor antagonists
GB0900756D0 EP4 Receptor antagonists
GB0900755D0 Ep4 receptor antagonists
GB0900754D0 EP4 Receptor antagonists
GB0820268D0 Novel synthetic method
GB0820263D0 Snythrtic method
GB0805036D0 New use of cyclopenta[g]quinazoline derivatives
GB0805035D0 Us eof cyclopenta[G]quinazoline derivatives
GB0803019D0 Fluorinated compounds
CN102950695A Device and method for producing therapeutic foam